Copyright Reports & Markets. All rights reserved.

Europe Recombinant Protein Market Report 2019

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Recombinant Protein Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Hormones Market Performance (Volume)
      • 2.1.2 Growth Factors Market Performance (Volume)
      • 2.1.3 Cytokines Market Performance (Volume)
      • 2.1.4 Plasma Protein Factor Market Performance (Volume)
      • 2.1.5 Recombinant Metabolic Enzymes Market Performance (Volume)
      • 2.1.6 Immune Checkpoint Regulators Market Performance (Volume)
      • 2.1.7 Others Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Hormones Market Performance (Value)
      • 2.2.2 Growth Factors Market Performance (Value)
      • 2.2.3 Cytokines Market Performance (Value)
      • 2.2.4 Plasma Protein Factor Market Performance (Value)
      • 2.2.5 Recombinant Metabolic Enzymes Market Performance (Value)
      • 2.2.6 Immune Checkpoint Regulators Market Performance (Value)
      • 2.2.7 Others Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Biopharmaceutical Companies Market Performance (Volume)
      • 3.1.2 Academic and Research Institutes Market Performance (Volume)
      • 3.1.3 Contract Research Organizations Market Performance (Volume)
      • 3.1.4 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Crown Bioscience
      • 4.1.1 Crown Bioscience Profiles
      • 4.1.2 Crown Bioscience Product Information
      • 4.1.3 Crown Bioscience Recombinant Protein Business Performance
      • 4.1.4 Crown Bioscience Recombinant Protein Business Development and Market Status
    • 4.2 BioVision
      • 4.2.1 BioVision Profiles
      • 4.2.2 BioVision Product Information
      • 4.2.3 BioVision Recombinant Protein Business Performance
      • 4.2.4 BioVision Recombinant Protein Business Development and Market Status
    • 4.3 ProSpec Tany TechnoGene
      • 4.3.1 ProSpec Tany TechnoGene Profiles
      • 4.3.2 ProSpec Tany TechnoGene Product Information
      • 4.3.3 ProSpec Tany TechnoGene Recombinant Protein Business Performance
      • 4.3.4 ProSpec Tany TechnoGene Recombinant Protein Business Development and Market Status
    • 4.4 Feldan Bio
      • 4.4.1 Feldan Bio Profiles
      • 4.4.2 Feldan Bio Product Information
      • 4.4.3 Feldan Bio Recombinant Protein Business Performance
      • 4.4.4 Feldan Bio Recombinant Protein Business Development and Market Status
    • 4.5 BPS Bioscience
      • 4.5.1 BPS Bioscience Profiles
      • 4.5.2 BPS Bioscience Product Information
      • 4.5.3 BPS Bioscience Recombinant Protein Business Performance
      • 4.5.4 BPS Bioscience Recombinant Protein Business Development and Market Status
    • 4.6 Sigma Aldrich Company
      • 4.6.1 Sigma Aldrich Company Profiles
      • 4.6.2 Sigma Aldrich Company Product Information
      • 4.6.3 Sigma Aldrich Company Recombinant Protein Business Performance
      • 4.6.4 Sigma Aldrich Company Recombinant Protein Business Development and Market Status
    • 4.7 Novoprotein Scientific
      • 4.7.1 Novoprotein Scientific Profiles
      • 4.7.2 Novoprotein Scientific Product Information
      • 4.7.3 Novoprotein Scientific Recombinant Protein Business Performance
      • 4.7.4 Novoprotein Scientific Recombinant Protein Business Development and Market Status
    • 4.8 PeproTech
      • 4.8.1 PeproTech Profiles
      • 4.8.2 PeproTech Product Information
      • 4.8.3 PeproTech Recombinant Protein Business Performance
      • 4.8.4 PeproTech Recombinant Protein Business Development and Market Status
    • 4.9 HumanZyme
      • 4.9.1 HumanZyme Profiles
      • 4.9.2 HumanZyme Product Information
      • 4.9.3 HumanZyme Recombinant Protein Business Performance
      • 4.9.4 HumanZyme Recombinant Protein Business Development and Market Status
    • 4.10 GenScript Biotech Corporation
      • 4.10.1 GenScript Biotech Corporation Profiles
      • 4.10.2 GenScript Biotech Corporation Product Information
      • 4.10.3 GenScript Biotech Corporation Recombinant Protein Business Performance
      • 4.10.4 GenScript Biotech Corporation Recombinant Protein Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Europe Recombinant Protein Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Europe Recombinant Protein Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Europe Recombinant Protein Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Europe Recombinant Protein Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Recombinant Protein Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 Germany Recombinant Protein Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 Germany Recombinant Protein Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 Germany Recombinant Protein Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Recombinant Protein Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 UK Recombinant Protein Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 UK Recombinant Protein Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 UK Recombinant Protein Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Recombinant Protein Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 France Recombinant Protein Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 France Recombinant Protein Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 France Recombinant Protein Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Recombinant Protein Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Russia Recombinant Protein Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Russia Recombinant Protein Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Russia Recombinant Protein Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Recombinant Protein Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Benelux Recombinant Protein Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Benelux Recombinant Protein Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Benelux Recombinant Protein Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Recombinant Protein Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 Italy Recombinant Protein Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 Italy Recombinant Protein Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 Italy Recombinant Protein Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Recombinant Protein Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Spain Recombinant Protein Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Spain Recombinant Protein Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Spain Recombinant Protein Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Recombinant Protein Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 Recombinant Protein Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 Recombinant Protein Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 Recombinant Protein Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Europe Recombinant Protein Market Performance (Sales Point)

    • 7.1 Europe Recombinant Protein Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Europe Recombinant Protein Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Europe Recombinant Protein Price (USD/Unit) by Regions 2014-2020
    • 7.4 Europe Recombinant Protein Gross Margin by Regions 2014-2020

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Recombinant Protein Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.2 Germany Recombinant Protein Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.3 UK Recombinant Protein Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 France Recombinant Protein Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.5 Russia Recombinant Protein Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.6 Benelux Recombinant Protein Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.7 Italy Recombinant Protein Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.8 Spain Recombinant Protein Sales and Growth, Sales Value and Growth Rate2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Biopharmaceutical Companies Industry
    • 11.2 Academic and Research Institutes Industry
    • 11.3 Contract Research Organizations Industry
    • 11.4 Others Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Europe Recombinant Protein Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Europe Recombinant Protein Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 Germany Recombinant Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 UK Recombinant Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 France Recombinant Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Russia Recombinant Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Benelux Recombinant Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 Italy Recombinant Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Spain Recombinant Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 Hormones Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.3 Growth Factors Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.4 Cytokines Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.5 Plasma Protein Factor Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.6 Recombinant Metabolic Enzymes Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.7 Immune Checkpoint Regulators Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.8 Others Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.3 Sales Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 Biopharmaceutical Companies Sales and and Growth Rate 2021-2026
      • 12.3.3 Academic and Research Institutes Sales and and Growth Rate 2021-2026
      • 12.3.4 Contract Research Organizations Sales and and Growth Rate 2021-2026
      • 12.3.5 Others Sales and and Growth Rate 2021-2026
    • 12.4 Price (USD/Unit) and Gross Profit Forecast
      • 12.4.1 Europe Recombinant Protein Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Europe Recombinant Protein Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, the Recombinant Protein market is expected to be valued at USD xxx billion by 2026, growing at a CAGR of xx% between 2020 and 2026. In this study, sales and sales value (million USD) of major players in Europe market will be included.
    Sales and revenue by type/application from 2014-2026.
    Industry chain, market trend, downstream and upstream information is also included.

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Recombinant Protein for these regions, from 2014 to 2026 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Recombinant Protein market competition by top manufacturers/players, with Recombinant Protein sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Crown Bioscience
    BioVision
    ProSpec Tany TechnoGene
    Feldan Bio
    BPS Bioscience
    Sigma Aldrich Company
    Novoprotein Scientific
    PeproTech
    HumanZyme
    GenScript Biotech Corporation

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Hormones
    Growth Factors
    Cytokines
    Plasma Protein Factor
    Recombinant Metabolic Enzymes
    Immune Checkpoint Regulators
    Others

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Recombinant Protein for each application, including
    Biopharmaceutical Companies
    Academic and Research Institutes
    Contract Research Organizations
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.
    Buy now